162 related articles for article (PubMed ID: 22114930)
21. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
[TBL] [Abstract][Full Text] [Related]
22. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
23. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado MI; Green AR
Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
[TBL] [Abstract][Full Text] [Related]
24. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
25. Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord.
Kovács GG; Andó RD; Adori C; Kirilly E; Benedek A; Palkovits M; Bagdy G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):193-203. PubMed ID: 17359360
[TBL] [Abstract][Full Text] [Related]
26. A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation.
Mechan AO; O'Shea E; Elliott JM; Colado MI; Green AR
Psychopharmacology (Berl); 2001 Jun; 155(4):413-8. PubMed ID: 11441431
[TBL] [Abstract][Full Text] [Related]
27. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI
Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996
[TBL] [Abstract][Full Text] [Related]
28. Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain.
Beveridge TJ; Mechan AO; Sprakes M; Pei Q; Zetterstrom TS; Green AR; Elliott JM
Psychopharmacology (Berl); 2004 May; 173(3-4):346-52. PubMed ID: 14735293
[TBL] [Abstract][Full Text] [Related]
29. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.
Itzhak Y; Ali SF; Achat CN; Anderson KL
Psychopharmacology (Berl); 2003 Mar; 166(3):241-8. PubMed ID: 12590354
[TBL] [Abstract][Full Text] [Related]
30. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
Battaglia G; Yeh SY; De Souza EB
Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
[TBL] [Abstract][Full Text] [Related]
31. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
Wang X; Baumann MH; Dersch CM; Rothman RB
Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
[TBL] [Abstract][Full Text] [Related]
32. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
[TBL] [Abstract][Full Text] [Related]
33. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
[TBL] [Abstract][Full Text] [Related]
34. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.
Malberg JE; Sabol KE; Seiden LS
J Pharmacol Exp Ther; 1996 Jul; 278(1):258-67. PubMed ID: 8764359
[TBL] [Abstract][Full Text] [Related]
35. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
[TBL] [Abstract][Full Text] [Related]
36. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.
Zhang L; Shirayama Y; Shimizu E; Iyo M; Hashimoto K
Eur J Pharmacol; 2006 Aug; 544(1-3):1-9. PubMed ID: 16859675
[TBL] [Abstract][Full Text] [Related]
38. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
39. Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain.
Puerta E; Barros-Miñones L; Hervias I; Gomez-Rodriguez V; Orejana L; Pizarro N; de la Torre R; Jordán J; Aguirre N
J Neurosci Res; 2012 Feb; 90(2):518-28. PubMed ID: 21948520
[TBL] [Abstract][Full Text] [Related]
40. Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.
Yubero-Lahoz S; Ayestas MA; Blough BE; Partilla JS; Rothman RB; de la Torre R; Baumann MH
Eur J Pharmacol; 2012 Jan; 674(2-3):337-44. PubMed ID: 22079770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
